Literature DB >> 16354370

Tubular apocrine adenoma with syringocystadenoma papilliferum arising from the external auditory canal.

Chi-Kyou Lee1, Kee-Taek Jang, Yang-Sun Cho.   

Abstract

Tubular apocrine adenoma (TAA) is a very rare sweat gland tumour. Comprehensive review of the literature reveals that TAA in the external auditory canal (EAC) has not yet been reported. We report a case of TAA in the EAC, together with characteristic histopathological findings.

Entities:  

Mesh：

Year:  2005        PMID： 16354370     DOI： 10.1258/002221505775010706

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN： 0022-2151            Impact factor:   1.469


  6 in total

1.  Syringocystadenoma Papilliferum in Co-existence with Tubular Apocrine Adenoma on the Calf.

Authors:  Jung Hee Yoon; Hyo Hyun Ahn; Young Chul Kye; Soo Hong Seo
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

2.  Syringocystadenoma papilliferum of the back combined with a tubular apocrine adenoma.

Authors:  Hyun Joo Lee; Eujin Cho; Min Ho Kim; Sang Hyun Cho; Jeong Deuk Lee
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

Review 3.  Ceruminous Neoplasms of the Ear.

Authors:  Priyadharsini Nagarajan
Journal:  Head Neck Pathol       Date:  2018-08-01

Review 4.  Lipomatous apocrine adenoma with syringocystadenoma papilliferum arising from the external auditory canal.

Authors:  Tzu-Cheng Su; Ko-Hung Shen; Hsin-kai Wang; Pei-Yi Chu; Mei-Ling Chen
Journal:  Head Neck Oncol       Date:  2011-08-22

5.  A Case of Tubular Apocrine Adenoma with Syringocystadenoma Papilliferum that Developed in a Nevus Sebaceus.

Authors:  Mi Sun Kim; June Hyunkyung Lee; Won-Mi Lee; Sook-Ja Son
Journal:  Ann Dermatol       Date:  2010-08-05       Impact factor: 1.444

6.  Syringocystadenoma papilliferum in the right lower abdomen: a case report and review of literature.

Authors:  Dong Xu; Tienan Bi; Huanrong Lan; Wenjie Yu; Wenmin Wang; Feilin Cao; Ketao Jin
Journal:  Onco Targets Ther       Date:  2013-03-26       Impact factor: 4.147
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.